INTEGRA THEOPHYLLINE * 0737917

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2001-08-16 for INTEGRA THEOPHYLLINE * 0737917 manufactured by Roche Diagnostics.

Event Text Entries

[17038209] Patient was admitted to the hospital due to falsely elevated theophylline result.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2001-00077
MDR Report Key326798
Report Source05
Date Received2001-08-16
Date of Report2001-03-29
Date of Event2001-03-16
Date Mfgr Received2001-03-17
Device Manufacturer Date2000-04-01
Date Added to Maude2001-04-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDEBARA REEK
Manufacturer Street9115 HUGUE ROAD
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175763857
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINTEGRA THEOPHYLLINE
Generic NameTHERAPEUTIC DRUG MONITORING ASSAY
Product CodeLGS
Date Received2001-08-16
Model Number*
Catalog Number0737917
Lot Number61346001
ID Number*
Device Expiration Date2002-05-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeNA
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key316202
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE RD. INDIANAPOLIS IN 46250 US
Baseline Brand NameTHEOPHYLLINE
Baseline Generic NameCLINICAL CHEMISTRY REAGENTS
Baseline Model NoNA
Baseline Catalog No0737917
Baseline IDNA
Baseline Device FamilyINTEGRA FAMILY OF ANALYZERS
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]24
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK951595
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2001-08-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.